# High-risk Antithrombotic Drugs at Discharge and Consultation for Hemorrhagic or Thromboembolic Events in the Emergency Department

> **NCT07278648** · — · NOT_YET_RECRUITING · sponsor: **Consorci Sanitari de l'Alt Penedès i Garraf** · enrollment: 150 (estimated)

## Conditions studied

- Acute Disease

## Interventions

- **OTHER:** Antithrombotic therapy

## Key facts

- **NCT ID:** NCT07278648
- **Lead sponsor:** Consorci Sanitari de l'Alt Penedès i Garraf
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-05
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07278648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07278648, "High-risk Antithrombotic Drugs at Discharge and Consultation for Hemorrhagic or Thromboembolic Events in the Emergency Department". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07278648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*